新型卵泡膜细胞标志物胰岛素样因子3与早发性卵巢功能不全相关
该回顾性队列研究纳入145名女性,包括48例早发性卵巢功能不全(POI)患者、49例生化POI(bPOI)患者和48名年龄匹配的卵巢储备正常对照,检测血清和卵泡液中胰岛素样因子3(INSL3)水平。结果显示血清INSL3随卵巢功能不全进展持续下降,与FSH呈强负相关(-0.655),与AMH(0.617)、AFC(0.630)等正相关,且能良好预测bPOI和POI;卵泡液INSL3在bPOI与对照间无显著差异。
要点
- 血清INSL3水平随卵巢功能不全进展而持续下降。
- 血清INSL3与FSH强负相关(-0.655),与AMH、AFC正相关。
- 血清INSL3可作为bPOI和POI的良好预测指标。
核心结论
- 首次揭示POI女性存在INSL3缺乏,提示循环INSL3可作为POI有前景的卵泡膜细胞特异性标志物。
研究设计与样本
- 回顾性队列研究,纳入2017至2019年山东大学附属生殖医院145名女性,包括48例POI(25 IU/L < FSH ≤40 IU/L)、49例bPOI(10 IU/L < FSH ≤25 IU/L)和48名年龄匹配的卵巢储备正常对照(FSH <10 IU/L)。
主要发现
- 血清INSL3水平随卵巢功能不全进展持续下降。
- 血清INSL3与FSH呈强负相关(-0.655),与LH负相关(-0.433),与AMH正相关(0.617)、抑制素B正相关(0.400)、AFC正相关(0.630)、睾酮正相关(0.180)。
- 循环INSL3对bPOI和POI具有良好的预测价值。
- bPOI患者与对照女性卵泡液INSL3水平无统计学显著差异。
临床怎么用
- 血清INSL3可作为评估卵巢功能不全阶段的候选卵泡膜细胞特异性标志物,辅助bPOI和POI的预测。
局限性
- 研究为回顾性设计,样本量有限,INSL3在卵泡发育、类固醇生成及POI发病机制中的作用尚需未来研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize circulating insulin-like factor 3 (INSL3) in different stages of ovarian insufficiency and its role in the evaluation of premature ovarian insufficiency (POI). DESIGN: Retrospective cohort study. SETTING: University-based center for reproductive medicine. PATIENT(S): A total of 145 women, including 48 patients with POI (25 IU/L < follicle-stimulating hormone [FSH] ≤40 IU/L), 49 with biochemical POI (bPOI) (10 IU/L < FSH ≤25 IU/L) and 48 age-matched control women with normal ovarian reserve (FSH <10 IU/L), retrospectively included from the reproductive hospital affiliated with Shandong University between 2017 and 2019. INTERVENTION(S): Levels of INSL3 in the serum and follicular fluid assayed with a commercial radioimmunoassay. MAIN OUTCOME MEASURE(S): Level of INSL3 in serum and follicular fluid among control women and patients with bPOI and POI, its association with different ovarian reserve markers, and its predictive value for bPOI and POI. RESULT(S): The serum INSL3 level continuously declined with the progress of ovarian insufficiency. It showed strong negative association with FSH (-0.655) and luteinizing hormone (-0.433), but positively correlated with antimüllerian hormone (0.617), inhibin B (0.400), antral follicle count (0.630), and testosterone (0.180). Additionally, the circulating INSL3 served as a good predictor for bPOI and POI. No statistically significant difference of INSL3 levels in follicular fluid was observed between bPOI patients and control women. CONCLUSION(S): For the first time our study has revealed an INSL3 deficiency in women with POI, indicating that circulating INSL3 could serve as a promising theca-cell specific marker for POI. Future research on the role of INSL3 in modulating follicular development, steroidogenesis, and POI pathogenesis is warranted.
引用
- Zhu C, Luo W, Li Z, et al. New theca-cell marker insulin-like factor 3 is associated with premature ovarian insufficiency. Fertil Steril. 2020. PMID: 33041054. doi:10.1016/j.fertnstert.2020.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。